Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_assertion type Assertion NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_head.
- NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_assertion description "[Sixty-one transplanted patients who had IgAN as an original disease (30 with biopsy-proved early recurrence, median 2.9 yr post-transplant), and 120 controls, were investigated for aberrantly glycosylated IgA1, IgA binding to mesangial matrix, macromolecular IgA (IgA/fibronectin and uteroglobulin/IgA/fibronectin complexes), and polymorphisms of cytokines tumor necrosis factor alpha (TNFalpha), interleukin 10 (IL-10), IL-6, interferon gamma and transforming growth factor beta 1 and renin-angiotensin system (angiotensinogen converting enzyme, angiotensin II receptor 1, and angiotensinogen) genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_provenance.
- NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_assertion evidence source_evidence_literature NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_provenance.
- NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_assertion SIO_000772 17988266 NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_provenance.
- NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_assertion wasDerivedFrom gad-20150221 NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_provenance.
- NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_assertion wasGeneratedBy ECO_0000203 NP84252.RAiuY_T_H6zVN6mxsBcPOY4JD0e4yx6rU6W9AKHNRlCt4130_provenance.